Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines - PubMed (original) (raw)

Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines

S Shimizu et al. J Exp Med. 1989.

Abstract

Two IL-6-dependent human multiple myeloma cell lines, ILKM2 and ILKM3, were established from the bone marrow of patients with IgG-K multiple myeloma. Both cell lines had the typical morphology and immunocytochemical features of myeloma cells. The surface phenotype of both cell lines was PCA-1+, OKT10+, CD10(J-5)-, CD19(B4)-, CD20(B1)-, CD21(B2)-, and OKIa-1-. A monoclonal cytoplasmic Ig, IgG-K or K L chain, was positive in ILKM2 or ILKM3, respectively. EBV nuclear antigen was negative in both cell lines. They proliferated in the presence of macrophages or macrophage-derived factors (MDF). Among the recombinant cytokines examined, IL-6 most strongly augmented the growth of both cell lines. The anti-IL-6 antibody completely inhibited the IL-6-dependent growth and almost completely inhibited the MDF- or purified MDF-dependent growth of both cell lines, ILKM2 and ILKM3 are now being maintained in the culture medium containing 2 ng/ml rIL-6. These results suggest that IL-6 produced by macrophages may play an important role in the growth of myeloma cells in vivo and that macrophages or IL-6 can be used for establishing human myeloma cell lines.

PubMed Disclaimer

Cited by

Prognostic significance of epidermal growth factor receptor and programmed cell death-ligand 1 co-expression in esophageal squamous cell carcinoma.
Jiang G, Miao Y, Wang Z, Zhang Q, Zhou P, Zhang F. Jiang G, et al. Aging (Albany NY). 2023 Feb 20;15(4):1107-1129. doi: 10.18632/aging.204535. Epub 2023 Feb 20. Aging (Albany NY). 2023. PMID: 36812484 Free PMC article.
Network-based modeling of drug effects on disease module in systemic sclerosis.
Kim KJ, Moon SJ, Park KS, Tagkopoulos I. Kim KJ, et al. Sci Rep. 2020 Aug 7;10(1):13393. doi: 10.1038/s41598-020-70280-y. Sci Rep. 2020. PMID: 32770109 Free PMC article.
CD56 expression in human myeloma cells derived from the neurogenic gene expression: possible role of the SRY-HMG box gene, SOX4.
Iqbal MS, Otsuyama K, Shamsasenjan K, Asaoku H, Kawano MM. Iqbal MS, et al. Int J Hematol. 2010 Mar;91(2):267-75. doi: 10.1007/s12185-009-0474-3. Epub 2010 Jan 5. Int J Hematol. 2010. PMID: 20049565
IL-6-induced activation of MYC is responsible for the down-regulation of CD33 expression in CD33+ myeloma cells.
Shamsasenjan K, Otsuyama KI, Abroun S, Iqbal MS, Mahmoud MS, Asaoku H, Kawano MM. Shamsasenjan K, et al. Int J Hematol. 2009 Apr;89(3):310-318. doi: 10.1007/s12185-009-0256-y. Epub 2009 Mar 4. Int J Hematol. 2009. PMID: 19259613
Frap, FKBP12 rapamycin-associated protein, is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tumor suppressor gene.
Bliskovsky V, Ramsay ES, Scott J, DuBois W, Shi W, Zhang S, Qian X, Lowy DR, Mock BA. Bliskovsky V, et al. Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14982-7. doi: 10.1073/pnas.2431627100. Epub 2003 Nov 21. Proc Natl Acad Sci U S A. 2003. PMID: 14634209 Free PMC article.

References

1. Blood. 1988 Nov;72(5):1826-8 - PubMed
1. Immunol Lett. 1988 Jan;17(1):41-5 - PubMed
1. Proc Soc Exp Biol Med. 1967 Aug-Sep;125(4):1246-50 - PubMed
1. J Immunol. 1972 Dec;109(6):1193-200 - PubMed
1. J Exp Med. 1974 Aug 1;140(2):494-507 - PubMed

MeSH terms

Substances

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Research Materials
- Cellosaurus - a cell line knowledge resource

Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines - PubMed (original) (raw)